Choose foreign counsel carefully, says Teva trademark head

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Choose foreign counsel carefully, says Teva trademark head

Larry Rickles, chief trademark counsel at Teva

Finding the right outside counsel and developing proper processes for search, clearance and filing are crucial to trademark prosecution outside your home jurisdiction, said Laurence Rickles

At this year’s Managing IP Global Trademark Forum in New York, Teva’s chief trademark counsel delved into the tumultuous world of foreign trademark work and gave advice on the best way to handle it

Laurence Rickles, who has been at Teva in New York since 2015, kicked off the session on Tuesday by advising delegates to choose their foreign external counsel carefully.

“Outside the US, it becomes difficult to work with local laws and customs, and you must rely on good external counsel to a certain extent,” he said. 

He said that membership of INTA is probably the lowest bar for entry for a new outside counsel partner, and that if a law firm was not a member of that organisation, he would probably question how much trademark work it really did.

Beyond that, he said, he has found referrals to be particularly useful when picking law firms in the past. “Often I will go to contacts or former colleagues at Novartis or Johnson & Johnson and say: ‘Hey, who do you use here?’” 

Another industry speaker on the panel noted that an in-house lawyer’s choice is also likely to be influenced by the law firm’s client service record. If the firm can offer fixed fees and is known for being communicative, it is far more likely to be picked by an in-house person who doesn’t know a jurisdiction particularly well and has few pre-existing relationships with other practices. 

“I imagine I’m not the only in-house person who gets pressure from finance to find firms that offer fixed fees. Those fee arrangements are quite common in the US, but are often difficult to find elsewhere.”

Country of choice

The next piece of advice speakers gave was not to conduct searches in every foreign jurisdiction. “You’re not going to do full searches in every country,” said Rickles at Teva. “Searching in 220 countries would be incredibly time consuming and expensive, and there are various ways to cut down this effort to make it more cost-effective.”

Speakers noted that counsel should also be aware that there more cost-effective ways to file trademark registrations than on a traditional country-by-country basis. Rickles said that in the EU, for example, it is a no-brainer to apply for EU trademarks rather than individual French, German or, until recently, UK marks. 

“We’ve also been trying to nudge paralegals and get them comfortable with Madrid filings,” he said. “We’re an Israeli company so we can take advantage of the Madrid Protocol more easily than a US-based company.”

He added: “The Madrid System is not as friendly towards US companies, but if you happen to work for a foreign firm, you can take advantage of the system to save money, which will help with your overall budget plan.” 



more from across site and SHARED ros bottom lb

More from across our site

Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Gift this article